Back

Antiplatelet therapy with cangrelor in patients undergoing surgery after coronary stent implantation: a real-world bridging protocol experience

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Percutaneous coronary syndrome: pharma and devices Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Roberta Rossini

Santa Croce E Carle Hospital, Cuneo (Italy)

26 More presentations in this session

Presentation thumbnail
Doctor G. Gallone (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor S. Dani (Ahmedabad, IN)
Presentation thumbnail
Doctor H. Matsuda (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Doctor I. Menown (Craigavon, GB)
Abstract
Presentation thumbnail
Miss L. Kerkmeijer (Zwolle, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022
thumbnail
Congress Presentation
Evaluation of myocardial reperfusion in patients undergoing cangrelor supported primary PCI for STEMI.
27 August 2021
thumbnail
Congress Presentation
Cangrelor in a Challenging Scenario: a Case Report of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI
25 March 2023
thumbnail
Congress Presentation
Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources